Article
Realgar bioleaching solution is a less toxic arsenic agent in suppressing the Ras/MAPK pathway in Caenorhabditis elegans.
Environmental toxicology and pharmacology - 1 Mar 2013
Liu Dongling, Zhi Dejuan, Zhou Ting, Yu Qinghong, Wan Fengqi, Bai Yanli, Li Hongyu
Abstract excerpt
To explore other arsenic derivatives with anticancer effects and fewer adverse effects, realgar bioleaching solution (RBS) has been found to be a viable approach. Here we used C. elegans as a model organism to its possible efficacy for anti-cancer effect of RBS. Our results indicated that RBS significantly suppressed the multivulva (Muv) phenotype of let-60 ras(gf) mutant that was positive correlated to arsenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
